Home068270 • KRX
add
Celltrion Inc
Nakaraang pagsara
₩176,000.00
Sakop ng araw
₩173,050.00 - ₩176,500.00
Sakop ng taon
₩144,615.31 - ₩188,800.00
Market cap
40.41T KRW
Average na Volume
466.80K
P/E ratio
70.90
Dividend yield
0.39%
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 961.46B | 9.91% |
Gastos sa pagpapatakbo | 301.28B | 2.01% |
Net na kita | 61.17B | -21.59% |
Net profit margin | 6.36 | -28.70% |
Kita sa bawat share | 276.00 | -20.06% |
EBITDA | 319.79B | 56.22% |
Aktuwal na % ng binabayarang buwis | -20.74% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 824.00B | -20.06% |
Kabuuang asset | 20.55T | 2.10% |
Kabuuang sagutin | 3.89T | 24.20% |
Kabuuang equity | 16.66T | — |
Natitirang share | 220.28M | — |
Presyo para makapag-book | 2.35 | — |
Return on assets | 2.93% | — |
Return on capital | 3.14% | — |
Cash Flow
Net change in cash
| (KRW) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 61.17B | -21.59% |
Cash mula sa mga operasyon | 188.14B | -35.92% |
Cash mula sa pag-invest | -115.46B | -211.15% |
Cash mula sa financing | -196.36B | 20.36% |
Net change in cash | -178.62B | -213.72% |
Malayang cash flow | 92.77B | -9.21% |
Tungkol
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Itinatag
2002
Website
Mga Empleyado
2,680
